Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate RBC transfusion independence (RBC-TI) of luspatercept compared with placebo for the treatment of anemia due to IPSS-R very low, low, or intermediate risk MDS in subjects with ring sideroblasts (≥ 15%) who require RBC transfusions
Inclusion criteria
- Subjects with ring sideroblasts who require regular Red Blood Cell (RBC) Transfusions due to anemia due to Myelodysplastic Syndromes (MDS)